P111 - Segurança CV da Dapagliflozina - estudo DECLARE - Carlos Eduardo Barra Couri SBD
-
- Science
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.
13 min